BIOR
Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
$0.22
+0.00% today
Updated 2026-04-30
Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$0 – $0
Volume
—
Biora Therapeutics Inc (BIOR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | $127.97M | $143.99M | $74.31M | $1.25M | $305000.00 | $4000.00 |
| Revenue growth (YoY) | — | +12.5% | -48.4% | -98.3% | -75.5% | -98.7% |
| Cost of revenue | $92.08M | $100.49M | $93.43M | $1.44M | $907000.00 | $555000.00 |
| Gross profit | $35.90M | $43.49M | $-19.12M | $1.25M | $305000.00 | $4000.00 |
| Gross margin | 28.1% | 30.2% | -25.7% | 100.0% | 100.0% | 100.0% |
| R&D | $48.71M | $63.40M | $47.74M | $45.78M | $24.05M | $29.84M |
| SG&A | $51.24M | $61.32M | $75.44M | $68.54M | $38.04M | $38.11M |
| Operating income | $-114.24M | $-140.12M | $-195.19M | $-117.84M | $-61.78M | $-67.14M |
| Operating margin | -89.3% | -97.3% | -262.7% | -9449.6% | -20256.1% | -1678575.0% |
| EBITDA | $-110.17M | $-135.44M | $-190.13M | $-164.57M | $-37.35M | $-114.05M |
| EBITDA margin | -86.1% | -94.1% | -255.8% | -13197.0% | -12246.9% | -2851350.0% |
| EBIT | $-114.77M | $-140.04M | $-195.19M | $-166.00M | $-38.26M | $-114.61M |
| Interest expense | $9.09M | $9.20M | $34.87M | $12.64M | $10.99M | $9.81M |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-129.11M | $-148.04M | $-192.53M | $-178.52M | $-38.16M | $-124.11M |
| Net income growth (YoY) | — | -14.7% | -30.1% | +7.3% | +78.6% | -225.3% |
| Profit margin | -100.9% | -102.8% | -259.1% | -14316.0% | -12510.5% | -3102875.0% |